jRCT2031240522招募中不适用
ONO-1110-05:A Phase IIa, Randomized, Double-blind, Placebo Controlled, Parallel Group, Multi-center Trial to Evaluate the Efficacy and Safety of ONO-1110 in Patients with Fibromyalgia
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 160
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized Controlled Trial
- 干预模型
- Parallel Assignment
- 主要目的
- Treatment Purpose
- 盲法
- Double Blind
入排标准
- 年龄范围
- 18age old over 至 No limit（—）
- 性别
- All
入选标准
- •Japanese (both sexes)
- •Patients who are considered capable of understanding the study procedures and completing the pain diary and questionnaires appropriately by the investigator (sub-investigator)
- •4.Patients who meet the American College of Rheumatology Fibromyalgia Criteria
排除标准
- •Patients with inflammatory arthritis, infectious arthritis, or autoimmune disease
- •Patients with pain other than FM that may affect assessments in this study
- •Patients with a past history of or concurrent neurologic diseases that may affect assessments in this study
- •Patients with a past history of or concurrent malignant tumor within 3 years
- •Patients who are pregnant, nursing, or possibly pregnant, or intending to become pregnant during the study period.
研究者
相似试验
招募中
不适用
ONO-1110-06:Phase IIa study of ONO-1110 in Patients with Hunner Type Interstitial CystitisjRCT2031240558Ono Pharmaceutical Co.,LTD50
招募中
不适用
ONO-1110-07:Phase IIa study of ONO-1110 in Patients with Major Depressive DisorderMajor Depressive DisorderjRCT2031240577Ono Pharmaceutical Co.,LTD100
招募中
不适用
ONO-1110-08:Phase IIa study of ONO-1110 in Patients with Social Anxiety DisorderSocial Anxiety DisorderjRCT2031240578Ono Pharmaceutical Co.,LTD100
未知
3 期
Study of ONO-1101 in Patients Scheduled for Multi-Slice CT, in an open-label, Multi-Center StudyCoronary artery diseaseJPRN-jRCT2080220774ONO PHARMACEUTICAL CO.,LTD.30
未知
2 期
Study of ONO-1101 in patients scheduled for coronary angiography.Coronary Artery DiseaseJPRN-jRCT2080220472ONO PHARMACEUTICAL CO.,LTD.